Resistance to antiplatelet drugs in patients with cardiovascular diseases and diabetes
Journal Title: Postępy Nauk Medycznych - Year 2013, Vol 26, Issue 3
Abstract
Treatment with antiplatelet drugs – aspirin (ASA) and clopidogrel – is a standard procedure in patients with cardiovascular disease, especially after ACS and invasive treatment. Despite this, cardiac events, including premature restenosis, occur in a number of patients. Such complications are partially ascribed to resistance to aspirin and/or clopidogrel. This phenomenon results in high on treatment platelet reactivity (HTPR) which seems to be more pronounced in patients with diabetes. There are several mechanism which may play a role in diabetic patients such as glycation of platelet proteins, increased platelet turnover, insulin resistance, oxidative stress, reduced bioavailability of the drugs or their metabolites. The frequency of cardiac events is associated with laboratory determined HTPR and cannot be significantly reduced by increasing doses of aspirin and clopidogrel. The way to overcome resistance to the above medicines is to use new antiplatelet drugs. Prasugrel and ticagrelor proved to be more effective than clopidogrel in reducing cardiac events in patients treated with PCI. These drugs are approved by ESC and AHA for treatment of ACS patients (with few exceptions e.g. excessive risk of major bleeding). Prasugrel appears to be especially effective in patients with diabetes. Triple antiplatelet therapy (with cilostazol added to ASA and clopidogrel) seems to offer some additional benefit in patients with diabetes but results of available studies are equivocal.
Authors and Affiliations
Wiesław Piechota
Comparison of procalcitonin levels in differentiating the causes of fever in children, depending on the diagnostic method
<b>Introduction.</b> In the diagnosis of fevers in children fast diagnostic tests are particularly valuable. They enable an early diagnosis of a disease and the implementation of appropriate t...
Treatment of peripheral vascular malformations – preliminary single-centre experience
Introduction. Vascular malformations present a serious diagnostic and therapeutic problem of modern medicine. They occur in 1.5% of human population and are equally common in both sexes. The symptoms of vascular malforma...
Nawrót FSGS w nerce przeszczepionej
Nawrót ogniskowego segmentalnego stwardnienia kłębuszków nerkowych w nerce przeszczepionej najczęściej rozpoznawany jest u chorych z wywiadem FSGS i masywnym białkomoczem we wczesnym okresie potransplantacyjnym. Wystąpie...
Vitamin D and gastrointestinal diseases
Skin synthesis, the main source of vitamin D supply is restricted by multiple factors e.g. latitude, weather conditions, season, clothes, sunscreen, patient age, melanin content in the skin. Thinking about these restrict...
Screening for diagnosis of early stages of diabetic kidney disease
Early diagnosis of diabetic nephropathy seems to be an important part of the evaluation of patients with diabetes. It allows early nephroprotective treatment and makes possible resulting decrease of chronic kidney diseas...